Ganesh Ragul, Rao Ravindra, Deb Koushik Sinha, Bhad Roshan, Yadav Deepak
Dept. of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Dept. of Psychiatry, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
Indian J Psychol Med. 2022 Jul;44(4):354-358. doi: 10.1177/02537176211027239. Epub 2021 Jul 29.
Integrating mobile technologies in healthcare (mHealth) is helpful to manage various medical conditions. mHealth applications can bridge the gap in the management of patients with opioid use disorder (OUD). Research evaluating the feasibility of mHealth to address OUD is limited in developing countries. We aimed to assess the digital capacity and interest in mHealth interventions in patients maintained on opioid agonist treatment (OAT).
150 patients on OAT from a community drug treatment clinic in New Delhi, India, were included. We assessed the participants on their pattern of mobile and Internet use and their willingness to use mHealth technology to access health information and services related to OUD.
88% of participants ( = 132) owned a mobile phone at assessment; 2.7% ( = 4) had never used a mobile phone in their lifetime. 70% ( = 105) participants had Internet access. 80% ( = 120) of participants showed interest in receiving text messages related to the management of OUD. 60% of participants showed a willingness to download and use applications for monitoring their substance use.
In India, there is an interest among people on OAT to use mHealth interventions to manage their substance use. This population also has access to mobile phones and the necessary knowledge to install and run applications needed for various mHealth interventions.
将移动技术整合到医疗保健中(移动医疗)有助于管理各种医疗状况。移动医疗应用程序可以弥合阿片类药物使用障碍(OUD)患者管理方面的差距。在发展中国家,评估移动医疗解决阿片类药物使用障碍可行性的研究有限。我们旨在评估接受阿片类激动剂治疗(OAT)的患者对移动医疗干预措施的数字能力和兴趣。
纳入了来自印度新德里一家社区药物治疗诊所的150名接受阿片类激动剂治疗的患者。我们评估了参与者的移动和互联网使用模式,以及他们使用移动医疗技术获取与阿片类药物使用障碍相关的健康信息和服务的意愿。
在评估时,88%的参与者(n = 132)拥有手机;2.7%(n = 4)一生中从未使用过手机。70%(n = 105)的参与者可以访问互联网。80%(n = 120)的参与者表示有兴趣接收与阿片类药物使用障碍管理相关的短信。60%的参与者表示愿意下载并使用应用程序来监测他们的药物使用情况。
在印度,接受阿片类激动剂治疗的人群有兴趣使用移动医疗干预措施来管理他们的药物使用。这一人群也能够使用手机,并且具备安装和运行各种移动医疗干预所需应用程序的必要知识。